Nonmelanoma skin cancer in inflammatory bowel disease: A review

Inflammatory Bowel Diseases

Volumn 17, Issue 6, 2011, Pages 1423-1427

  Long, Millie D ^a,c   Kappelman, Michael D ^a   Pipkin, Clare A ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

anti TNF agents; immunosuppression; inflammatory bowel disease; nonmelanoma skin cancer; prevention

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; AZATHIOPRINE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FERULIC ACID; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; LEFLUNOMIDE; MERCAPTOPURINE; METHOTREXATE; POLYPHENOL DERIVATIVE; POLYPODIUM LEUCOTOMOS EXTRACT; PREDNISONE; SUNSCREEN; TIOGUANINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CANCER INCIDENCE; CANCER PATIENT; CANCER PREVENTION; CANCER SCREENING; CROHN DISEASE; DISEASE ASSOCIATION; DRUG INDUCED CANCER; ENTERITIS; HUMAN; NONHUMAN; NONMELANOMA SKIN CANCER; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SECONDARY PREVENTION; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ULCERATIVE COLITIS; ULTRAVIOLET A RADIATION;

ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; SKIN NEOPLASMS;

EID: 79955818117     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21484     Document Type: Review

References (31)

1. Rogers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States. Arch Dermatol. 2006; 146: 283-287.
2. Leiter U, Garbe C., Epidemiology of melanoma and nonmelanoma skin cancerâthe role of sunlight. Adv Exp Med Biol. 2008; 624: 89-103.
3. Arora A, Attwood J., Common skin cancers and their precursors. Surg Clin North Am. 2009; 89: 703-712.
4. Ponten F, Lundeberg J., Principles of tumor biology and pathogenesis of BCC's and SCC's. Dermatology, 2nd ed. London: Harcourt Health Publishers; 2003: 1627-1639.
5. Maddox JS, Soltani K., Risk of nonmelanoma skin cancer with azathioprine use. Inflamm Bowel Dis. 2008; 14: 1425-1431.
6. Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol. 2003; 48: 425-429. (Pubitemid 36337080)
7. Friedman GD, Tekawa IS., Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control. 2000; 11: 891-897. (Pubitemid 32005300)
8. Efird JT, Friedman GD, Habel L, et al. Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol. 2002; 12: 469-475.
9. Lindelof B, Sigurgeirsson B, Gabel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000; 143: 513-519.
10. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999; 40: 177-186. (Pubitemid 29072794)
11. Euvrard S, Kanitakis J, Claudy A., Skin cancers after organ transplantation. N Engl J Med. 2003; 348: 1681-1691. (Pubitemid 36459475)
12. Long MD, Herfarth HH, Pipkin C, et al. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2009; 8: 268-274.
13. Mellemkjaer L, Olsen JH, Frisch M, et al. Cancer in patients with ulcerative colitis. Int J Cancer. 1995; 60: 330-333.
14. Ekbom A, Helmick C, Zack M, et al. Extracolonic malignancies in inflammatory bowel disease. Cancer. 1991; 67: 2015-2019.
15. Chakravarty EF, Michaud K, Wolfe F., Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. J Rheumatol. 2005; 32: 2130-2135. (Pubitemid 41587856)
16. Amari W, Zeringue AL, McDonald JR, et al. Non-melanoma and melanoma skin cancer risk in a national cohort of veterans with rheumatoid arthritis [abstract]. Arthritis Rheum. 2009; 60 (suppl 10): 1379.
17. Mercer LK, Galloway JB, Lunt M, et al. The influence of anti-TNF therapy upon incidence of non-melanoma skin cancer (NMSC) in patients with rheumatoid arthritis (RA): results from the BSR Biologics Register (BSRBR) [abstract]. Arthritis Rheum. 2009; 60 (suppl 10): 2062.
18. Wei Q, Matanoski GM, Farmer ER, et al. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci U S A. 1993; 90: 1614-1618. (Pubitemid 23058224)
19. Parrish JA., Immunosuppression, skin cancer, and ultraviolet A radiation. N Engl J Med. 2005; 353: 2712-2713. (Pubitemid 41817723)
20. Rodust PM, Stockfleth E, Ulrich C, et al. UV-induced squamous cell carcinomaâa role for antiapoptotic signalling pathways. Br J Dermatol. 2009; 161 (suppl 3): 107-115.
21. O'Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science. 2005; 309: 1871-1874. (Pubitemid 41325100)
22. Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006; 295: 2275-2285. (Pubitemid 43736578)
23. Balkwill F., Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 2002; 13: 135-141. (Pubitemid 34229388)
24. Hengge UR., Role of viruses in the development of squamous cell cancer and melanoma. Adv Exp Med Biol. 2008; 624: 179-186.
25. Screening for skin cancer: U.S., Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 150: 188-193.
26. Wang SQ, Balagula Y, Osterwalder U., Photoprotection: a review of the current and future technologies. Dermatol Ther. 2010; 23: 31-47.
27. Available at:. Accessed 1 April 2010.
28. Bolognia JL, Jorizzo JL, Rapini RP, et al. Dermatology, 2nd ed. London: Elsevier; 2008.
29. Hofbauer GF, Anliker M, Arnold A, et al. Swiss clinical practice guidelines for skin cancer in organ transplant recipients. Swiss Med Wkly. 2009; 139: 407-415.
30. EBPG Expert Group on Renal Transplantation: European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV. 6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment. Nephrol Dial Transplant. 2002; 17 (suppl 4): 31-36.
31. Kasiske BL, Vazquez MA, Harmon WE, et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol. 2000; 11 (suppl 15): S1-S86.